The relationship between mean corpuscular hemoglobin concentration and mortality in hypertensive individuals: A population-based cohort study

• Published in: PloS one Vol. 19; no. 5; p. e0301903
• Main Authors: Li, Dan, Zhang, Qing, Ruan, Zhishen, Zhang, Yue, Liu, Xiaohe, Zhang, Guihong, Zhao, Hengyi, Li, Jing, Wu, Bo
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 09.05.2024; Public Library of Science (PLoS)
• Subjects: Adult; Age; Aged; Anemia; Blood pressure; Body mass index; Cardiovascular disease; Cardiovascular diseases; Cardiovascular Diseases - blood; Cardiovascular Diseases - mortality; China; Chronic obstructive pulmonary disease; Cohort Studies; Confidence intervals; Diabetes; Erythrocyte Indices; Female; Health aspects; Heart attacks; Heart failure; Hematology; Hemoglobin; Hemoglobins - analysis; Hemoglobins - metabolism; Humans; Hyperlipidemia; Hypertension; Hypertension - blood; Hypertension - mortality; Kidney diseases; Male; Marital status; Matching; Medical prognosis; Medical research; Medicine and Health Sciences; Medicine, Experimental; Middle Aged; Mortality; Nutrition Surveys; Patient outcomes; Physiological aspects; Population studies; Prognosis; Proportional Hazards Models; Pulmonary embolisms; Risk factors; Smoking; Statistical analysis; Subgroups; Surveys; Variables; Viscosity; China
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0301903

Hematology is an essential field for investigating the prognostic outcomes of cardiovascular diseases (CVDs). Recent research has suggested that mean corpuscular hemoglobin concentration (MCHC) is associated with a poor prognosis in several CVDs. There is no evidence of a correlation between MCHC and hypertension. Therefore, our study aimed to analyze the association of MCHC with all-cause and cardiovascular mortality in hypertensive patients. We used cohort data from U.S. adults who participated in the National Health and Nutrition Examination Survey from 1999-2014. COX regression was applied to analyze the relationship between MCHC and all-cause and cardiovascular mortality. In addition, three models were adjusted to reduce confounding factors. We reanalyzed the data after propensity score matching (PSM) to inspect the stability of the results. Stratified analysis was additionally adopted to investigate the results of each subgroup. Our research included 15,154 individuals. During a mean follow-up period of 129 months, 30.6% of the hypertensive population succumbed to mortality. Based on previous studies, we categorized patients with MCHC ≤33mg/dl as the hypochromia group and those with >33mg/dl as the non-hypochromia group. After PSM, the hypochromia group had higher all-cause mortality (adjusted hazard ratio [HR]:1.26, 95% confidence interval [95%CI]:1.11-1.43) and cardiovascular mortality (adjusted HR:1.42, 95%CI:1.12-1.80) than the non-hypochromia group. The results of the COX regression remain stable after matching. Stratified analyses before PSM revealed an interaction of anemia in the relationship between MCHC and mortality, whereas there was no significant interaction after matching. In hypertensive individuals, low MCHC was correlated with a poor prognosis. Further studies on MCHC are necessary to analyze the potential mechanisms of its poor prognosis in hypertensive populations.